Related Articles
LOW ACTIVITY OF CIRCADIAN CONTINUOUS FLUORODEOXYURIDINE (FUDR) CHEMOTHERAPY IN POOR-PROGNOSIS METASTATIC RENAL-CANCER
Hepatic toxicity during regorafenib treatment in patients with metastatic gastrointestinal stromal tumors
Serum carcinoembryonic antigen (CEA) correlates with the survival time during 5-FU hepatic arterial infusion chemotherapy for unresectable colorectal hepatic metastases
Repeated hepatic arterial infusion chemotherapy using an implanted port system in patients with unresectable malignant liver neoplasms: Significant factors affecting early hepatic arterial occlusion
Antineoplaston treatment for advanced hepatocellular carcinoma.